Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) Return on Sales (2024 - 2025)

Connect Biopharma Holdings' Return on Sales history spans 2 years, with the latest figure at 1075.0% for Q3 2025.

  • For Q3 2025, Return on Sales fell 106444.0% year-over-year to 1075.0%; the TTM value through Sep 2025 reached 69.02%, down 6350.0%, while the annual FY2024 figure was 0.6%, N/A changed from the prior year.
  • Return on Sales for Q3 2025 was 1075.0% at Connect Biopharma Holdings, down from 23.45% in the prior quarter.
  • Across five years, Return on Sales topped out at 8.98% in Q1 2025 and bottomed at 1075.0% in Q3 2025.